Adherence to imatinib therapy is the critical factor for achieving molecular responses in patients with chronic myeloid leukaemia
BRITISH JOURNAL OF HAEMATOLOGY(2010)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
BRITISH JOURNAL OF HAEMATOLOGY(2010)